toxylact: a04ad11 nabilone

The first professional lActological database in the word

This ATC class (A04AD11) comprises synthetic cannabinoid antiemetics, with nabilone as the representative drug, and available data indicate that its use during breastfeeding is generally not recommended due to insufficient safety evidence and potential risks to the infant.medpedia.framar+7

Overview and ATC classification

Nabilone is a synthetic cannabinoid categorized in ATC group A04AD11, within the broader class of other antiemetics used primarily for chemotherapy-induced nausea and vomiting when conventional agents fail.wikipedia+2
It acts centrally on cannabinoid receptors and is structurally and pharmacologically similar to delta‑9‑tetrahydrocannabinol, with additional use in some regions as an adjunct for neuropathic pain and appetite stimulation.drugbank+2

Indications and clinical use

Nabilone is indicated for the control of severe nausea and vomiting associated with cancer chemotherapy, especially in patients refractory to standard antiemetic regimens.medicines+2
In some countries, off‑label or extended use includes management of chronic neuropathic pain and appetite stimulation in cachectic states, although these indications are not universally approved.sjhc.london+2

Typical adult dosing for chemotherapy‑related emesis is 1–2 mg orally twice daily, starting 1–3 hours before chemotherapy and continuing as needed, with a maximum of 6 mg per day in divided doses.hivclinic+2
Onset of action is about 60–90 minutes, and the duration of clinical effect ranges between 8 and 12 hours, which guides dosing intervals.sjhc.london

Pharmacology and toxicology

Nabilone exerts complex effects on the central nervous system via activation of cannabinoid receptors, modulating emetic pathways and perception of nausea.medpedia.framar+1
Common pharmacodynamic outcomes include antiemetic effects, alterations in mood and cognition, and changes in cardiovascular parameters such as blood pressure.wikipedia+3

Frequent adverse reactions include dizziness, drowsiness, impaired concentration, unsteadiness, dry mouth, headache, and subjective euphoria.hivclinic+2
Less common but clinically significant toxic effects involve confusion, mood changes (anxiety, depression), hallucinations, hypotension or hypertension, respiratory difficulties, and arrhythmias, which may indicate overdose or heightened sensitivity.medpedia.framar+2

Nabilone should be used cautiously in patients with underlying psychiatric disorders, cardiovascular disease, and in the elderly, where CNS and hemodynamic effects may be more pronounced.accessdata.fda+2
It is contraindicated in individuals with hypersensitivity to nabilone or excipients and generally avoided during pregnancy due to insufficient safety data and potential fetal risk.pdf.hres+4

Lactation safety (toxico‑lactological assessment)

There are no adequate controlled studies assessing nabilone transfer into human milk or its effects on breastfed infants, and drug excretion into breast milk has not been reliably characterized.mayoclinic+3
Given its lipophilicity and CNS‑active cannabinoid profile, theoretical concerns include accumulation in milk, neurobehavioral depression, impaired feeding, and potential long‑term neurodevelopmental impact on the infant.nhs+4

Regulatory product information and patient guidance documents consistently state that nabilone should not be used in breastfeeding women, or that its use is not recommended due to unknown milk passage and potential risks.accessdata.fda+4
Expert breastfeeding resources similarly note that many CNS‑active and narcotic‑class drugs require extreme caution or avoidance during lactation, and recommend prioritizing safer, better‑studied antiemetics where clinically appropriate.sps+2

From a toxicological‑lactological standpoint, nabilone and related A04AD11 synthetic cannabinoid antiemetics should be considered incompatible with breastfeeding, and alternative antiemetic strategies should be preferred in nursing mothers whenever feasible.sps+6
If exposure during lactation were unavoidable in exceptional circumstances, this would warrant individualized risk–benefit evaluation, specialist consultation, and usually temporary interruption of breastfeeding, though such scenarios remain outside standard recommended practice.infantrisk+2

Practical considerations for healthcare professionals

Before prescribing nabilone to a woman of childbearing age, clinicians should systematically assess pregnancy and breastfeeding status and document counselling on reproductive and lactation risks.medicines+4
Safer antiemetics with established lactation data (e.g. certain dopamine antagonists, antihistamines or 5‑HT3 antagonists, depending on local guidance) should be prioritized when treating nausea and vomiting in breastfeeding patients.nhs+1

In cases where nabilone has been inadvertently taken during breastfeeding, the infant should be monitored for sedation, poor suck, feeding difficulties, changes in tone or behavior, and abnormal respiration, and breastfeeding management should be reviewed urgently.infantrisk+3
Documentation of exposure, dose, timing relative to feeds, and infant clinical status is important for ongoing risk assessment and for any future pharmacovigilance reporting.pdf.hres+2

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.